Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates

被引：16

作者：

Dayoub, Elias J. ^{[1
,2
,3
]}

Ross, Joseph S. ^{[4
,5
,6
]}

Shah, Nilay D. ^{[7
,8
]}

Dhruva, Sanket S. ^{[9
,10
]}

机构：

[1] Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA

[2] Univ Penn, Ctr Cardiovasc Outcomes Qual & Evaluat Res, Philadelphia, PA 19104 USA

[3] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA

[4] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, New Haven, CT USA

[5] Yale Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT USA

[6] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA

[7] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA

[8] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA

[9] San Francisco Vet Affairs Med Ctr, San Francisco, CA USA

[10] Univ Calif San Francisco, Sch Med, Dept Med, Div Cardiol, San Francisco, CA 94143 USA

来源：

CIRCULATION | 2019年 / 140卷 / 14期

关键词：

anticoagulants; atrial fibrillation; Medicare Part C; Medicare Part D; venous thrombembolism;

D O I：

10.1161/CIRCULATIONAHA.119.040580

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1227 / 1230

页数：4

共 5 条

[1]

[Anonymous], MED D

[2]

[Anonymous], 2018, MEDICARE D

[3]

January CT, 2019, CIRCULATION, V140, pE125, DOI [10.1161/CIR.0000000000000665, 10.1016/j.jacc.2019.01.011]

[4]

January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040

[5] Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report [J].

Kearon, Clive ;

Akl, Elie A. ;

Ornelas, Joseph ;

Blaivas, Allen ;

Jimenez, David ;

Bounameaux, Henri ;

Huisman, Menno ;

King, Christopher S. ;

Morris, Timothy A. ;

Sood, Namita ;

Stevens, Scott M. ;

Vintch, Janine R. E. ;

Wells, Philip ;

Woller, Scott C. ;

Moores, Lisa .

CHEST, 2016, 149 (02) :315-352

← 1 →